1. European recommendations for management of immune checkpoint inhibitors‐derived dermatologic adverse events. The EADV task force 'Dermatology for cancer patients' position statement. (15th December 2021) Authors: Apalla, Z.; Nikolaou, V.; Fattore, D.; Fabbrocini, G.; Freites‐Martinez, A.; Sollena, P.; Lacouture, M.; Kraehenbuehl, L.; Stratigos, A.; Peris, K.; Lazaridou, E.; Richert, B.; Vigarios, E.; Riganti, J.; Baroudjian, B.; Filoni, A.; Dodiuk‐Gad, R.; Lebbé, C.; Sibaud, V. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 3(2022) Page Start: 332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗